Chemoinformaics analysis of Aloesone
Molecular Weight | 232.235 | nRot | 2 |
Heavy Atom Molecular Weight | 220.139 | nRig | 13 |
Exact Molecular Weight | 232.074 | nRing | 2 |
Solubility: LogS | -2.255 | nHRing | 1 |
Solubility: LogP | 1.456 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
nHA | 4 | APOL | 32.9195 |
nHD | 1 | BPOL | 15.5105 |
QED | 0.859 |
Synth | 2.549 |
Natural Product Likeliness | 1.395 |
NR-PPAR-gamma | 0.213 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.996 |
HIA | 0.008 |
CACO-2 | -4.725 |
MDCK | 0.0000156 |
BBB | 0.028 |
PPB | 0.796186 |
VDSS | 0.902 |
FU | 0.218016 |
CYP1A2-inh | 0.959 |
CYP1A2-sub | 0.906 |
CYP2c19-inh | 0.567 |
CYP2c19-sub | 0.323 |
CYP2c9-inh | 0.38 |
CYP2c9-sub | 0.931 |
CYP2d6-inh | 0.17 |
CYP2d6-sub | 0.831 |
CYP3a4-inh | 0.147 |
CYP3a4-sub | 0.368 |
CL | 6.83 |
T12 | 0.808 |
hERG | 0.027 |
Ames | 0.21 |
ROA | 0.077 |
SkinSen | 0.623 |
Carcinogencity | 0.035 |
EI | 0.685 |
Respiratory | 0.144 |
NR-Aromatase | 0.198 |
Antiviral | No |
Prediction | 0.676621 |